Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Penile Squamous Cell Carcinoma.

PMID: 22261674
Journal: Actas dermo-sifiliograficas
Year: 2012
Reference: Actas Dermosifiliogr. 2012 Jul-Aug;103(6):478-87. doi: 10.1016/j.ad.2011.08.008. Epub 2012 Jan 17.
Impact factor:
Publication type: Letter or abstract
Authors: , , et al.
DOI: 10.1016/j.ad.2011.08.008

[Perception of work environment of nurses in hospitals of the Spanish national health system. RN4CAST-Spain project].

PMID: 23043730
Journal: Enfermeria clinica
Year: 2012
Reference: Enferm Clin. 2012 Sep;22(5):261-8. doi: 10.1016/j.enfcli.2012.09.001. Epub 2012 Oct 6.
Impact factor:
Publication type: Letter or abstract
Authors: Fuentelsaz-Gallego, Carmen, Moreno-Casbas, Teresa, Lopez-Zorraquino, David, Gomez-Garcia, Teresa, Gonzalez-Maria, Esther et al.
DOI: 10.1016/j.enfcli.2012.09.001

Percutaneous interface biopsy in dry-aspiration cases of chronic periprosthetic joint infections: A technique for preoperative isolation of the infecting organism.

PMID: 22124526
Journal: INTERNATIONAL ORTHOPAEDICS
Year: 2012
Reference: Int Orthop. 2012 Jun;36(6):1281-6. Epub 2011 Nov 30.
Impact factor: 2.025
Publication type: Paper in international publication
Authors: , , , , , , et al.
DOI: 10.1007/s00264-011-1418-0

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.

PMID: 22402756
Journal: GENETICS IN MEDICINE
Year: 2012
Reference: Genet Med. 2012 Jul;14(7):670-80. doi: 10.1038/gim.2012.18. Epub 2012 Mar 8.
Impact factor: 4.762
Publication type: Paper in international publication
Authors: Casey, Graham, Mercado, Rowena C, Hampel, Heather, Kastrinos, Fay, Steyerberg, Ewout, Balmana, Judith, Stoffel, Elena, Cohn, David E, Backes, Floor J, Hopper, John L et al.
DOI: 10.1038/gim.2012.18

Perioperative use of prothrombin complex concentrates.

PMID: 22357373
Journal: Minerva Anestesiologica
Year: 2012
Reference: Minerva Anestesiol. 2012 Mar;78(3):358-68.
Impact factor: 2.656
Publication type: Review in international publication
Authors: Colomina, M J, Diez Lobo, A, Garutti, I, Gomez-Luque, A, Llau, J V, Pita, E et al.
DOI:

Persistent Angina Pectoris, Cardiac Mortality and Myocardial Infarction During a 12 Year Follow-Up in 273 Variant Angina Patients Without Significant Fixed Coronary Stenosis.

PMID: 22835410
Journal: AMERICAN JOURNAL OF CARDIOLOGY
Year: 2012
Reference: Am J Cardiol. 2012 Nov 1;110(9):1249-55. doi: 10.1016/j.amjcard.2012.06.026. Epub 2012 Jul 25.
Impact factor: 3.368
Publication type: Paper in international publication
Authors: Figueras, Jaume, Domingo, Enric, Ferreira, Ignacio, Lidon, Rosa Maria, Garcia-Dorado, David et al.
DOI: 10.1016/j.amjcard.2012.06.026

Personality profile of adult ADHD: The alternative five factor model.

PMID: 22386569
Journal: PSYCHIATRY RESEARCH
Year: 2012
Reference: Psychiatry Res. 2012 Jun 30;198(1):130-4. doi: 10.1016/j.psychres.2011.11.006. Epub 2012 Mar 3.
Impact factor: 2.524
Publication type: Paper in international publication
Authors: , , , , , , , , et al.
DOI: 10.1016/j.psychres.2011.11.006

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

PMID: 22393084
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2012
Reference: J Clin Oncol. 2012 May 10;30(14):1594-600. doi: 10.1200/JCO.2011.37.4207. Epub 2012 Mar 5.
Impact factor: 18.372
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1200/JCO.2011.37.4207

Phase 1 Pharmacokinetic/Pharmacodynamic Study of MLN8237 - An Investigational, Oral, Selective Aurora A Kinase Inhibitor - In Patients With Advanced Solid Tumors.

PMID: 22753585
Journal: CLINICAL CANCER RESEARCH
Year: 2012
Reference: Clin Cancer Res. 2012 Sep 1;18(17):4764-74. doi: 10.1158/1078-0432.CCR-12-0571. Epub 2012 Jul 2.
Impact factor: 7.742
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1158/1078-0432.CCR-12-0571

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

PMID: 22162589
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2012
Reference: J Clin Oncol. 2012 Jan 20;30(3):282-90. Epub 2011 Dec 12.
Impact factor: 18.372
Publication type: Paper in international publication
Authors: Bendell, Johanna C, Rodon, Jordi, Burris, Howard A, de Jonge, Maja, Verweij, Jaap, Birle, Diana, Demanse, David, De Buck, Stefan S, Ru, Qinhua C, Peters, Malte et al.
DOI: 10.1200/JCO.2011.36.1360

Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors.

PMID: 22382883
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Year: 2012
Reference: Cancer Chemother Pharmacol. 2012 Jun;69(6):1467-75. doi: 10.1007/s00280-012-1856-4. Epub 2012 Mar 1.
Impact factor: 2.833
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1007/s00280-012-1856-4

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

PMID: 22357447
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 Sep;23(9):2399-408. doi: 10.1093/annonc/mds011. Epub 2012 Feb 22.
Impact factor: 6.425
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1093/annonc/mds011

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

PMID: 32018716
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 Sep;23(9):2399-2408. doi: 10.1093/annonc/mds011. Epub 2019 Dec 4.
Impact factor: 6.425
Publication type: Paper in international publication
Authors: Markman, B, Tabernero, J, Siu, L, Chen, L C, Mita, M, Melendez Cuero, M, Stutvoet, S, Birle, D, Anak, O, Hackl, W et al.
DOI: 10.1093/annonc/mds011

Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.

PMID: 21576284
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 Feb;23(2):463-71. Epub 2011 May 16.
Impact factor: 6.425
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1093/annonc/mdr137

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy.

PMID: 32018583
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 May;23(5):1241-1249. doi: 10.1093/annonc/mdr380. Epub 2019 Dec 4.
Impact factor: 6.425
Publication type: Paper in international publication
Authors: de Bono, J S, Molife, L R, Sonpavde, G, Maroto, J P, Calvo, E, Cartwright, T H, Loesch, D M, Feit, K, Das, A, Zang, E A et al.
DOI: 10.1093/annonc/mdr380

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy.

PMID: 21903605
Journal: ANNALS OF ONCOLOGY
Year: 2012
Reference: Ann Oncol. 2012 May;23(5):1241-1249. doi: 10.1093/annonc/mdr380. Epub 2011 Sep 7.
Impact factor: 6.425
Publication type: Paper in international publication
Authors: de Bono, J S, Molife, L R, Sonpavde, G, Maroto, J P, Calvo, E, Cartwright, T H, Loesch, D M, Feit, K, Das, A, Zang, E A et al.
DOI: 10.1093/annonc/mdr380

Photodynamic therapy for symptomatic subretinal fluid related to choroidal nevus.

PMID: 22366902
Journal: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Year: 2012
Reference: Retina. 2012 May;32(5):936-41. doi: 10.1097/IAE.0b013e318232c366.
Impact factor: 2.812
Publication type: Paper in international publication
Authors: , , , , , , , , et al.
DOI: 10.1097/IAE.0b013e318232c366

Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients.

PMID: 22154652
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2012
Reference: Eur J Cancer. 2012 Mar;48(4):594-6. Epub 2011 Dec 7.
Impact factor: 5.536
Publication type: Letter whit IF
Authors: Sessa, Cristiana, Evans, Jeff, Wilson, Richard, Plummer, Ruth, Gianni, Luca, del Conte, Gianluca, Penel, Nicolas, Ang, Joo Ern, Gomez-Roca, Carlos, Morales-Barrera, Rafael et al.
DOI: 10.1016/j.ejca.2011.11.004

Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease.

PMID: 22162184
Journal: MOVEMENT DISORDERS
Year: 2012
Reference: Mov Disord. 2012 Mar;27(3):439-42. doi: 10.1002/mds.24062. Epub 2011 Dec 9.
Impact factor: 4.505
Publication type: Paper in international publication
Authors: Walli, J, Cubo, Esther, Gonzalez, Miguel, del Puerto, Ines, de Yebenes, Justo Garcia, Arconada, Olga Fernandez, Gabriel y Galan, Jose Maria Trejo, Zangerl, A, Seppi, K, Wenning, G et al.
DOI: 10.1002/mds.24062

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

PMID: 22992072
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2012
Reference: N Engl J Med. 2012 Sep 20;367(12):1087-97.
Impact factor: 53.298
Publication type: Paper in international publication
Authors: Vurdelja, Ranka Baraba, Yang, Minhua, Raghupathi, Kartik, Novas, Mark, Sweetser, Marianne T, Viglietta, Vissia, Dawson, Katherine T, Fox, Robert J, Phillips, J Theodore, Hutchinson, Michael et al.
DOI: 10.1056/NEJMoa1206328

Placebo-controlled trial of oral laquinimod for multiple sclerosis.

PMID: 22417253
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2012
Reference: N Engl J Med. 2012 Mar 15;366(11):1000-9.
Impact factor: 53.298
Publication type: Paper in international publication
Authors: Petrov, I, Kappos, L, Montalban, X, McFarland, H, Bauer, K, Galay, N, Larrey, D, Metz, L, White, W, Filippi, M et al.
DOI: 10.1056/NEJMoa1104318

Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice.

PMID: 22503922
Journal: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Year: 2012
Reference: Biochim Biophys Acta. 2012 Jul;1820(7):894-9. doi: 10.1016/j.bbagen.2012.03.020. Epub 2012 Apr 5.
Impact factor: 5
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1016/j.bbagen.2012.03.020

Plasma beta-Amyloid Levels in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke.

PMID: 22261638
Journal: Neurodegenerative Diseases
Year: 2012
Reference: Neurodegener Dis. 2012;10(1-4):320-3. Epub 2012 Jan 17.
Impact factor: 3.056
Publication type: Paper in international publication
Authors: , , , , , , , , et al.
DOI: 10.1159/000333811

Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations.

PMID: 21457126
Journal: AIDS RESEARCH AND HUMAN RETROVIRUSES
Year: 2012
Reference: AIDS Res Hum Retroviruses. 2012 Feb;28(2):156-64. Epub 2011 May 6.
Impact factor: 2.246
Publication type: Paper in international publication
Authors: , , , , , , , , , et al.
DOI: 10.1089/AID.2010.0370

Publications

Publications searcher

Penile Squamous Cell Carcinoma.

[Perception of work environment of nurses in hospitals of the Spanish national health system. RN4CAST-Spain project].

Percutaneous interface biopsy in dry-aspiration cases of chronic periprosthetic joint infections: A technique for preoperative isolation of the infecting organism.

Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.

Perioperative use of prothrombin complex concentrates.

Persistent Angina Pectoris, Cardiac Mortality and Myocardial Infarction During a 12 Year Follow-Up in 273 Variant Angina Patients Without Significant Fixed Coronary Stenosis.

Personality profile of adult ADHD: The alternative five factor model.

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Phase 1 Pharmacokinetic/Pharmacodynamic Study of MLN8237 - An Investigational, Oral, Selective Aurora A Kinase Inhibitor - In Patients With Advanced Solid Tumors.

Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

Phase I dose-escalation study of vinflunine hard capsules administered twice a day for 2 consecutive days every week in patients with advanced/metastatic solid tumors.

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors.

Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy.

Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy.

Photodynamic therapy for symptomatic subretinal fluid related to choroidal nevus.

Pitfalls and limitations of a single-centre, retrospectively derived prognostic score for phase I oncology trial participants - reply to Fussenich et al.: a new, simple and objective prognostic score for phase I cancer patients.

Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Placebo-controlled trial of oral laquinimod for multiple sclerosis.

Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice.

Plasma beta-Amyloid Levels in Cerebral Amyloid Angiopathy-Associated Hemorrhagic Stroke.

Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations.

Patronage:

Collaborating:

Accreditations: